CD8A and liver cancer: Results from a study by Schietinger et al. based on a tamoxifen-inducible liver cancer mouse model indicate that although day 8 and day 30 TCRSV40-I-specific CD8+ T cells expressed similar exhaustion genes compared to LCMV clone 13 CD8+ T cells, distinct signatures were associated with each setting (50).